Industry: Medical Devices & Consumables
Published Date: 2025-01-13
Pages: 106 Pages
Report ld: 3499387
Request Sample
Customized Report
Submucosal Tissue Lifting Agent Market Size(US$)

CAGR 2025-2031
6.1%
Market Size,2031
USD 254
Million
Market Snapshot
Source: Secondary research, interviews with experts, and QYResearch analysis
The global market for Submucosal Tissue Lifting Agent was estimated to be worth US$ 169 million in 2024 and is forecast to a readjusted size of US$ 254 million by 2031 with a CAGR of 6.1% during the forecast period 2025-2031.
Submucosal Tissue Lifting Agent is a medical device that is an injectable liquid composition intended for use in gastrointestinal endoscopic procedures for submucosal lift of polyps, adenomas, early stage cancers or other gastrointestinal mucosal lesions, prior to removal with a snare or endoscopic device.
With the continuous advancement of medical technology, submucosal tissue lifting using injection agents has emerged as an innovative medical approach, garnering increasing attention and adoption. This technique involves injecting specific solutions into the submucosal layer, causing localized tissue elevation to facilitate diagnostic, therapeutic, and surgical procedures under endoscopic guidance. This method holds potential advantages in early screening and treatment of gastrointestinal pathologies, not only enhancing lesion visibility but also reducing surgical risks and recovery times. The market for this technology is exhibiting a steady growth trajectory, driven by its application prospects in the field of minimally invasive interventions. As awareness of health rises and the demand for early disease diagnosis and treatment increases, the development and application of submucosal tissue lifting solutions have gained momentum. Simultaneously, ongoing innovations in medical devices and pharmaceuticals provide robust support for the refinement and wider adoption of this technique. However, challenges such as standardization of technical protocols and accumulation of clinical evidence still exist in the market, necessitating close collaboration between relevant manufacturers and healthcare institutions to collectively propel the advancement of this field.
This report aims to provide a comprehensive presentation of the global market for Submucosal Tissue Lifting Agent, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Submucosal Tissue Lifting Agent by region & country, by Type, and by Application.
The Submucosal Tissue Lifting Agent market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Submucosal Tissue Lifting Agent.
MARKET SEGMENTATION
CHAPTER OUTLINE
Chapter 1: Introduces the report scope of the report, global total market size (value, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Submucosal Tissue Lifting Agent manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Submucosal Tissue Lifting Agent in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Submucosal Tissue Lifting Agent in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Market Overview
1.1 Submucosal Tissue Lifting Agent Product Introduction
1.2 Global Submucosal Tissue Lifting Agent Market Size Forecast
1.2.1 Global Submucosal Tissue Lifting Agent Sales Value (2020-2031)
1.2.2 Global Submucosal Tissue Lifting Agent Sales Volume (2020-2031)
1.2.3 Global Submucosal Tissue Lifting Agent Sales Price (2020-2031)
1.3 Submucosal Tissue Lifting Agent Market Trends & Drivers
1.3.1 Submucosal Tissue Lifting Agent Industry Trends
1.3.2 Submucosal Tissue Lifting Agent Market Drivers & Opportunity
1.3.3 Submucosal Tissue Lifting Agent Market Challenges
1.3.4 Submucosal Tissue Lifting Agent Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Submucosal Tissue Lifting Agent Players Revenue Ranking (2024)
2.2 Global Submucosal Tissue Lifting Agent Revenue by Company (2020-2025)
2.3 Global Submucosal Tissue Lifting Agent Players Sales Volume Ranking (2024)
2.4 Global Submucosal Tissue Lifting Agent Sales Volume by Company Players (2020-2025)
2.5 Global Submucosal Tissue Lifting Agent Average Price by Company (2020-2025)
2.6 Key Manufacturers Submucosal Tissue Lifting Agent Manufacturing Base and Headquarters
2.7 Key Manufacturers Submucosal Tissue Lifting Agent Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Submucosal Tissue Lifting Agent
2.9 Submucosal Tissue Lifting Agent Market Competitive Analysis
2.9.1 Submucosal Tissue Lifting Agent Market Concentration Rate (2020-2025)
2.9.2 Global 5 and 10 Largest Manufacturers by Submucosal Tissue Lifting Agent Revenue in 2024
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Submucosal Tissue Lifting Agent as of 2024)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Prefilled Syringe Type
3.1.2 Ampoule Type
3.2 Global Submucosal Tissue Lifting Agent Sales Value by Type
3.2.1 Global Submucosal Tissue Lifting Agent Sales Value by Type (2020 VS 2024 VS 2031)
3.2.2 Global Submucosal Tissue Lifting Agent Sales Value, by Type (2020-2031)
3.2.3 Global Submucosal Tissue Lifting Agent Sales Value, by Type (%) (2020-2031)
3.3 Global Submucosal Tissue Lifting Agent Sales Volume by Type
3.3.1 Global Submucosal Tissue Lifting Agent Sales Volume by Type (2020 VS 2024 VS 2031)
3.3.2 Global Submucosal Tissue Lifting Agent Sales Volume, by Type (2020-2031)
3.3.3 Global Submucosal Tissue Lifting Agent Sales Volume, by Type (%) (2020-2031)
3.4 Global Submucosal Tissue Lifting Agent Average Price by Type (2020-2031)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Hospitals
4.1.2 Ambulatory Surgical Centers
4.1.3 Specialty Clinics
4.2 Global Submucosal Tissue Lifting Agent Sales Value by Application
4.2.1 Global Submucosal Tissue Lifting Agent Sales Value by Application (2020 VS 2024 VS 2031)
4.2.2 Global Submucosal Tissue Lifting Agent Sales Value, by Application (2020-2031)
4.2.3 Global Submucosal Tissue Lifting Agent Sales Value, by Application (%) (2020-2031)
4.3 Global Submucosal Tissue Lifting Agent Sales Volume by Application
4.3.1 Global Submucosal Tissue Lifting Agent Sales Volume by Application (2020 VS 2024 VS 2031)
4.3.2 Global Submucosal Tissue Lifting Agent Sales Volume, by Application (2020-2031)
4.3.3 Global Submucosal Tissue Lifting Agent Sales Volume, by Application (%) (2020-2031)
4.4 Global Submucosal Tissue Lifting Agent Average Price by Application (2020-2031)
5 Segmentation by Region
5.1 Global Submucosal Tissue Lifting Agent Sales Value by Region
5.1.1 Global Submucosal Tissue Lifting Agent Sales Value by Region: 2020 VS 2024 VS 2031
5.1.2 Global Submucosal Tissue Lifting Agent Sales Value by Region (2020-2025)
5.1.3 Global Submucosal Tissue Lifting Agent Sales Value by Region (2026-2031)
5.1.4 Global Submucosal Tissue Lifting Agent Sales Value by Region (%), (2020-2031)
5.2 Global Submucosal Tissue Lifting Agent Sales Volume by Region
5.2.1 Global Submucosal Tissue Lifting Agent Sales Volume by Region: 2020 VS 2024 VS 2031
5.2.2 Global Submucosal Tissue Lifting Agent Sales Volume by Region (2020-2025)
5.2.3 Global Submucosal Tissue Lifting Agent Sales Volume by Region (2026-2031)
5.2.4 Global Submucosal Tissue Lifting Agent Sales Volume by Region (%), (2020-2031)
5.3 Global Submucosal Tissue Lifting Agent Average Price by Region (2020-2031)
5.4 North America
5.4.1 North America Submucosal Tissue Lifting Agent Sales Value, 2020-2031
5.4.2 North America Submucosal Tissue Lifting Agent Sales Value by Country (%), 2024 VS 2031
5.5 Europe
5.5.1 Europe Submucosal Tissue Lifting Agent Sales Value, 2020-2031
5.5.2 Europe Submucosal Tissue Lifting Agent Sales Value by Country (%), 2024 VS 2031
5.6 Asia Pacific
5.6.1 Asia Pacific Submucosal Tissue Lifting Agent Sales Value, 2020-2031
5.6.2 Asia Pacific Submucosal Tissue Lifting Agent Sales Value by Region (%), 2024 VS 2031
5.7 South America
5.7.1 South America Submucosal Tissue Lifting Agent Sales Value, 2020-2031
5.7.2 South America Submucosal Tissue Lifting Agent Sales Value by Country (%), 2024 VS 2031
5.8 Middle East & Africa
5.8.1 Middle East & Africa Submucosal Tissue Lifting Agent Sales Value, 2020-2031
5.8.2 Middle East & Africa Submucosal Tissue Lifting Agent Sales Value by Country (%), 2024 VS 2031
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Submucosal Tissue Lifting Agent Sales Value Growth Trends, 2020 VS 2024 VS 2031
6.2 Key Countries/Regions Submucosal Tissue Lifting Agent Sales Value
6.2.1 Key Countries/Regions Submucosal Tissue Lifting Agent Sales Value, 2020-2031
6.2.2 Key Countries/Regions Submucosal Tissue Lifting Agent Sales Volume, 2020-2031
6.3 United States
6.3.1 United States Submucosal Tissue Lifting Agent Sales Value, 2020-2031
6.3.2 United States Submucosal Tissue Lifting Agent Sales Value by Type (%), 2024 VS 2031
6.3.3 United States Submucosal Tissue Lifting Agent Sales Value by Application, 2024 VS 2031
6.4 Europe
6.4.1 Europe Submucosal Tissue Lifting Agent Sales Value, 2020-2031
6.4.2 Europe Submucosal Tissue Lifting Agent Sales Value by Type (%), 2024 VS 2031
6.4.3 Europe Submucosal Tissue Lifting Agent Sales Value by Application, 2024 VS 2031
6.5 China
6.5.1 China Submucosal Tissue Lifting Agent Sales Value, 2020-2031
6.5.2 China Submucosal Tissue Lifting Agent Sales Value by Type (%), 2024 VS 2031
6.5.3 China Submucosal Tissue Lifting Agent Sales Value by Application, 2024 VS 2031
6.6 Japan
6.6.1 Japan Submucosal Tissue Lifting Agent Sales Value, 2020-2031
6.6.2 Japan Submucosal Tissue Lifting Agent Sales Value by Type (%), 2024 VS 2031
6.6.3 Japan Submucosal Tissue Lifting Agent Sales Value by Application, 2024 VS 2031
6.7 South Korea
6.7.1 South Korea Submucosal Tissue Lifting Agent Sales Value, 2020-2031
6.7.2 South Korea Submucosal Tissue Lifting Agent Sales Value by Type (%), 2024 VS 2031
6.7.3 South Korea Submucosal Tissue Lifting Agent Sales Value by Application, 2024 VS 2031
6.8 Southeast Asia
6.8.1 Southeast Asia Submucosal Tissue Lifting Agent Sales Value, 2020-2031
6.8.2 Southeast Asia Submucosal Tissue Lifting Agent Sales Value by Type (%), 2024 VS 2031
6.8.3 Southeast Asia Submucosal Tissue Lifting Agent Sales Value by Application, 2024 VS 2031
6.9 India
6.9.1 India Submucosal Tissue Lifting Agent Sales Value, 2020-2031
6.9.2 India Submucosal Tissue Lifting Agent Sales Value by Type (%), 2024 VS 2031
6.9.3 India Submucosal Tissue Lifting Agent Sales Value by Application, 2024 VS 2031
7 Company Profiles
7.1 Seikagaku
7.1.1 Seikagaku Company Information
7.1.2 Seikagaku Introduction and Business Overview
7.1.3 Seikagaku Submucosal Tissue Lifting Agent Sales, Revenue, Price and Gross Margin (2020-2025)
7.1.4 Seikagaku Submucosal Tissue Lifting Agent Product Offerings
7.1.5 Seikagaku Recent Development
7.2 Ovesco Endoscopy
7.2.1 Ovesco Endoscopy Company Information
7.2.2 Ovesco Endoscopy Introduction and Business Overview
7.2.3 Ovesco Endoscopy Submucosal Tissue Lifting Agent Sales, Revenue, Price and Gross Margin (2020-2025)
7.2.4 Ovesco Endoscopy Submucosal Tissue Lifting Agent Product Offerings
7.2.5 Ovesco Endoscopy Recent Development
7.3 Boston Scientific
7.3.1 Boston Scientific Company Information
7.3.2 Boston Scientific Introduction and Business Overview
7.3.3 Boston Scientific Submucosal Tissue Lifting Agent Sales, Revenue, Price and Gross Margin (2020-2025)
7.3.4 Boston Scientific Submucosal Tissue Lifting Agent Product Offerings
7.3.5 Boston Scientific Recent Development
7.4 The Standard
7.4.1 The Standard Company Information
7.4.2 The Standard Introduction and Business Overview
7.4.3 The Standard Submucosal Tissue Lifting Agent Sales, Revenue, Price and Gross Margin (2020-2025)
7.4.4 The Standard Submucosal Tissue Lifting Agent Product Offerings
7.4.5 The Standard Recent Development
7.5 GI Supply
7.5.1 GI Supply Company Information
7.5.2 GI Supply Introduction and Business Overview
7.5.3 GI Supply Submucosal Tissue Lifting Agent Sales, Revenue, Price and Gross Margin (2020-2025)
7.5.4 GI Supply Submucosal Tissue Lifting Agent Product Offerings
7.5.5 GI Supply Recent Development
7.6 Cosmo Pharmaceuticals
7.6.1 Cosmo Pharmaceuticals Company Information
7.6.2 Cosmo Pharmaceuticals Introduction and Business Overview
7.6.3 Cosmo Pharmaceuticals Submucosal Tissue Lifting Agent Sales, Revenue, Price and Gross Margin (2020-2025)
7.6.4 Cosmo Pharmaceuticals Submucosal Tissue Lifting Agent Product Offerings
7.6.5 Cosmo Pharmaceuticals Recent Development
7.7 Micro-Tech Endoscopy
7.7.1 Micro-Tech Endoscopy Company Information
7.7.2 Micro-Tech Endoscopy Introduction and Business Overview
7.7.3 Micro-Tech Endoscopy Submucosal Tissue Lifting Agent Sales, Revenue, Price and Gross Margin (2020-2025)
7.7.4 Micro-Tech Endoscopy Submucosal Tissue Lifting Agent Product Offerings
7.7.5 Micro-Tech Endoscopy Recent Development
7.8 EndoClot Plus
7.8.1 EndoClot Plus Company Information
7.8.2 EndoClot Plus Introduction and Business Overview
7.8.3 EndoClot Plus Submucosal Tissue Lifting Agent Sales, Revenue, Price and Gross Margin (2020-2025)
7.8.4 EndoClot Plus Submucosal Tissue Lifting Agent Product Offerings
7.8.5 EndoClot Plus Recent Development
8 Industry Chain Analysis
8.1 Submucosal Tissue Lifting Agent Industrial Chain
8.2 Submucosal Tissue Lifting Agent Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Submucosal Tissue Lifting Agent Sales Model
8.5.2 Sales Channel
8.5.3 Submucosal Tissue Lifting Agent Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global Submucosal Tissue Lifting Agent market was valued at US$ 121 million in 2025 and is anticipated to reach US$ 202 million by 2032, at a CAGR of 7.7% from 2026 to 2032.
Published Date: 2026-04-17
Pages: 114
USD 2900.00
(Single User License)
The global Submucosal Tissue Lifting Agent market size was US$ 121 million in 2025 and is forecast to reach a readjusted size of US$ 202 million by 2032 with a CAGR of 7.7% during the forecast period 2026-2032.
Published Date: 2026-03-09
Pages: 76
USD 4250.00
(Single User License)
The global market for Submucosal Tissue Lifting Agent was estimated to be worth US$ 121 million in 2025 and is projected to reach US$ 202 million, growing at a CAGR of 7.7% from 2026 to 2032.
Published Date: 2026-03-06
Pages: 92
USD 3950.00
(Single User License)
The global market for Submucosal Tissue Lifting Agent was estimated to be worth US$ 113 million in 2024 and is forecast to a readjusted size of US$ 189 million by 2031 with a CAGR of 7.7% during the forecast period 2025-2031.
Published Date: 2025-12-11
Pages: 109
USD 3950.00
(Single User License)
The global Submucosal Tissue Lifting Agent market size was US$ 113 million in 2024 and is forecast to a readjusted size of US$ 189 million by 2031 with a CAGR of 7.7% during the forecast period 2025-2031.
Published Date: 2025-12-11
Pages: 80
USD 4250.00
(Single User License)
The global Submucosal Tissue Lifting Agent market is projected to grow from US$ 113 million in 2024 to US$ 189 million by 2031, at a CAGR of 7.7% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-12-11
Pages: 136
USD 4900.00
(Single User License)
The global market for Submucosal Tissue Lifting Agent was valued at US$ 113 million in the year 2024 and is projected to reach a revised size of US$ 189 million by 2031, growing at a CAGR of 7.7% during the forecast period.
Published Date: 2025-12-11
Pages: 111
USD 2900.00
(Single User License)
Submucosal Tissue Lifting Agent is a medical device that is an injectable liquid composition intended for use in gastrointestinal endoscopic procedures for submucosal lift of polyps, adenomas, early stage cancers or other gastrointestinal mucosal lesions, prior to removal with a snare or endoscopic device.
Published Date: 2024-01-17
Pages: 79
USD 2900.00
(Single User License)
The global Submucosal Tissue Lifting Agent market was valued at US$ 121 million in 2025 and is anticipated to reach US$ 202 million by 2032, at a CAGR of 7.7% from 2026 to 2032.
Published: 2026-04-17
Pages: 114
The global Submucosal Tissue Lifting Agent market size was US$ 121 million in 2025 and is forecast to reach a readjusted size of US$ 202 million by 2032 with a CAGR of 7.7% during the forecast period 2026-2032.
Published: 2026-03-09
Pages: 76
The global market for Submucosal Tissue Lifting Agent was estimated to be worth US$ 121 million in 2025 and is projected to reach US$ 202 million, growing at a CAGR of 7.7% from 2026 to 2032.
Published: 2026-03-06
Pages: 92
The global market for Submucosal Tissue Lifting Agent was estimated to be worth US$ 113 million in 2024 and is forecast to a readjusted size of US$ 189 million by 2031 with a CAGR of 7.7% during the forecast period 2025-2031.
Published: 2025-12-11
Pages: 109
The global Submucosal Tissue Lifting Agent market size was US$ 113 million in 2024 and is forecast to a readjusted size of US$ 189 million by 2031 with a CAGR of 7.7% during the forecast period 2025-2031.
Published: 2025-12-11
Pages: 80
The global Submucosal Tissue Lifting Agent market is projected to grow from US$ 113 million in 2024 to US$ 189 million by 2031, at a CAGR of 7.7% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-12-11
Pages: 136
The global market for Submucosal Tissue Lifting Agent was valued at US$ 113 million in the year 2024 and is projected to reach a revised size of US$ 189 million by 2031, growing at a CAGR of 7.7% during the forecast period.
Published: 2025-12-11
Pages: 111
Submucosal Tissue Lifting Agent is a medical device that is an injectable liquid composition intended for use in gastrointestinal endoscopic procedures for submucosal lift of polyps, adenomas, early stage cancers or other gastrointestinal mucosal lesions, prior to removal with a snare or endoscopic device.
Published: 2024-01-17
Pages: 79
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now